Emerging Therapies for Chronic Spontaneous Urticaria: Understanding How They Work

Join this expert discussion on the role of IgE in the pathogenesis of CSU and therapies in development.

The goal of this activity is to increase understanding of the pathophysiology of chronic spontaneous urticaria (CSU), the role of immunoglobulin E (IgE), and how novel emerging therapies targeting IgE differ from already approved biologic drugs.

You can find this activity here: https://www.medscape.org/viewarticle/949259

Author: Allen P. Kaplan, MD; Alexander Eggel, PhD - From Medscape Education, April 2021

At EAACI 2021 touchIMMUNOLOGY were delighted to talk with Professor Marcus Maurer (Charité – Universitätsmedizin Berlin, Berlin, Germany) to discuss the Phase 1a study of CDX-0159 in patients with chronic inducible urticaria.

Read more

The overall aim of this webinar is to improve the management and awareness of solar urticaria and its differential diagnoses by learning about the clinical spectrum of UV-light induced skin diseases

Read more

In this episode, Dr Young-Min Ye shares the findings of her cutting-edge research into predictors of remission in chronic urticaria, and explains what is currently known about the role of Mas-related G protein coupled receptor X2 (MRGPRX2) in the activation of mast cells.

Link: https://www.medthority.com/csu-learning-zone/podcast-series/

Read more

How do comorbidities affect patients with chronic spontaneous urticaria and what can be done to minimise their impact? Find out more on this crucial, yet understudied topic from our latest guest, Dr Simon Francis Thomsen.


Read more

In this episode, our host is joined by Dr Moshe Ben-Shoshan, who shares his pioneering approach to treating paediatric patients and draws on his experience to debunk some of the common myths surrounding childhood urticaria.


Read more

In this episode, our host is joined by UK-based dermatologist Dr Clive Grattan to address some of the most important unanswered questions in the field of chronic spontaneous urticaria.

LINK: www.medthority.com/csu-learning-zone/podcast-series/

Read more

Join Drs Martin Metz and Ana Maria Giménez-Arnau as they discuss the latest data on new treatments in development for chronic spontaneous urticaria.

The goal of this activity is to educate on the latest therapeutic developments for the management of patients with chronic spontaneous urticaria (CSU)


Martin Metz, MD; Ana Maria...

Read more

We are very pleased to announce that this year’s UCARE Conference will be held on December 9th-11th, 2021 in Hiroshima, Japan.

Read more

Dear members of the UCARE and ACARE networks,

we regret to inform you about the passing of one of our esteemed members:

Professor Marek L. Kowalski (1952-2021),

Read more

In this very special episode, our host meets Cassandra, a patient who has been affected by CSU for many years. Listen now for unmissable insights into the patient experience and to find out more about what you do to better support your own patients in the future. 

LINK: https://www.medthority.com/csu-learning-zone/podcast-series/

Read more

Contact us

GA²LEN coordinating Office
Robert-Koch-Platz 7
10115 Berlin, Germany

UCARE office
Laura Schwenner